Minoxidil and finasteride are the floor, not the ceiling. Here's how RU58841, microneedling, dutasteride, LLLT and PRP layer on top, and where adding more agents stops paying for itself.
Minoxidil plus oral finasteride is the baseline that most retention protocols are built on, and for the average user it does most of the heavy lifting. The interesting question for anyone past their first year on the basics is what to add when the response plateaus, when shedding resumes, or when AAS use raises the DHT exposure beyond what 1mg of finasteride can blunt. The honest answer: a small number of additions are reliably worth the trouble, and most of the rest are cope.
Before stacking anything exotic, the base needs to be optimized. Most "non-responders" are actually under-dosed or non-compliant on the fundamentals.
If any of those four pillars is missing or half-assed, fix that before paying for RU58841 or a laser cap.
RU58841 and pyrilutamide (KX-826) are topical androgen receptor antagonists. They block DHT at the follicle without meaningfully suppressing serum DHT, which is exactly the profile a looksmaxxer on cycle wants - scalp protection without compounding the systemic 5-AR suppression already coming from oral dut.
Reported community use:
RU58841 is the one to add when:
It is not a finasteride replacement for the average natural user - the systemic 5-AR pathway suppression from oral therapy is doing work that topical AR blockade doesn't fully replicate. Stack, don't substitute.
Low-dose daily tadalafil (2.5-5mg) shows up in hair stacks for a reason: PDE5 inhibition improves scalp perfusion, helps blunt the blood-pressure cost of oral minoxidil, and a small 2018 trial suggested independent benefit on AGA. It's not a primary agent, but for a user already running min/fin/dut who wants one more lever - and who would benefit from the on-cycle blood pressure and pump effects anyway - it's a cheap, well-tolerated addition.
Hard contraindication: tadalafil must not be combined with nitrates or nitric-oxide donors (severe hypotension risk). That includes recreational nitrate use.
| Addition | Verdict | Notes |
|---|---|---|
| Microneedling 1.5mm weekly | Add early | Highest ROI after min/fin. Synergizes with topicals via penetration + wound-healing signaling. |
| Dutasteride (replacing fin) | Add when fin plateaus or on AAS | Stronger DHT suppression; longer washout if sides appear. |
| RU58841 | Add for AAS users or stubborn hairline | Topical AR blockade without further systemic 5-AR hit. |
| Topical fin/dut | Reasonable swap | Lower serum DHT suppression than oral; useful for sides-sensitive users, weaker for heavy AAS contexts. |
| Oral minoxidil | Strong base swap | Better adherence and density than topical for many. Watch BP and edema. |
| LLLT (laser caps) | Marginal | Real but small effect. Worth it only if budget is non-issue and the rest of the stack is locked in. |
| PRP | Marginal, expensive | Some responders, no standardized protocol. As one community review put it, "While PRP and LLLT show promise, standardized protocols are necessary." |
| Topical retinoids (tretinoin 0.025%) | Niche add | Mixed with minoxidil to enhance penetration, 2-3x weekly. Irritation is the limiter. |
| Ketoconazole 2% shampoo | Cheap freebie | Mild anti-androgen at the scalp, 2-3x weekly. No reason not to. |
| Pyrilutamide | Optional RU alternative | Less experimental vehicle, weaker reported response. |
This is where most users fail. The hair cycle is slow, shedding is noisy, and confirmation bias runs both directions.
A mature stack for an aggressive looksmaxxer or AAS user looks like: oral dut 0.5mg daily, oral or topical minoxidil, RU58841 nightly, microneedling weekly at 1.5mm, ketoconazole shampoo 2-3x weekly, low-dose daily tadalafil. That's six agents and it covers every meaningful mechanism - 5-AR inhibition, AR blockade at the follicle, vasodilation/growth signaling, wound-healing induction, scalp microbiome, and perfusion.
Adding PRP injections, LLLT caps, oral biotin megadoses, exosomes, or a seventh topical on top of that protocol is where cost and complexity start outrunning the marginal benefit. The follicle has finite genetic ceiling. Once the major pathways are covered, more agents mostly add irritation, expense, and confounded data.
Min/fin is the baseline; microneedling at 1.5mm and a switch to dutasteride are the two highest-leverage upgrades. RU58841 is the right third agent for AAS users and for hairlines that won't hold on dut alone. Tadalafil and ketoconazole are cheap accessories that round out the stack. Everything past that - PRP, LLLT, exosomes, stacking three topicals - is optional polish. Lock in the base, photograph every 90 days, change one thing at a time, and give each addition six months before judging it.
Powered by BTST